Drug approvals and failures: implications for alliances

Jürgen Drews, Stefan Ryser, Innovation Deficit in the Pharmaceutical Industry Drug Information Journal. ,vol. 30, pp. 97- 108 ,(1996) , 10.1177/009286159603000113

Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler, Chantal Mathieu, Leonard Kaufman, Geoff Hale, Frans Gorus, Michel Goldman, Markus Walter, Sophie Candon, Liliane Schandene, Laurent Crenier, Christophe De Block, Jean-Marie Seigneurin, Pieter De Pauw, Denis Pierard, Ilse Weets, Peppy Rebello, Pru Bird, Eleanor Berrie, Mark Frewin, Herman Waldmann, Jean-François Bach, Daniel Pipeleers, Lucienne Chatenoud, Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. The New England Journal of Medicine. ,vol. 352, pp. 2598- 2608 ,(2005) , 10.1056/NEJMOA043980